Stryker — Apr 30, 2026 release
Fiscal 2026 first-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000310764-26-000025
Showing in the filing
Organic net sales growth
“8.0% to 9.5%”
Period
FY2026
Measure
Company-defined measure
Source
Prose
All guidance in this release · 2
Organic net sales growth for FY2026
“8.0% to 9.5%”
Adjusted net earnings per diluted share for FY2026
“$14.90 to $15.10”
Exhibit 99.1 · the passage around this item
… earlier in the release
Adjusted net earnings (1) of $1.0 billion decreased 8.5% in the quarter. Adjusted net earnings per diluted share (1) of $2.60 decreased 8.5% in the quarter. 2026 Outlook We are maintaining our full year 2026 guidance of organic net sales growth (2) in the range of 8.0% to 9.5% and adjusted net earnings per diluted share (2) in the range of $14.90 to $15.10. Our sales guidance includes a modestly positive pricing impact. Additionally, foreign exchange is expected to have a slightly favorable impact on both sales and adjusted net earnings per diluted share (2) should rates hold near current levels. (1) A reconciliation of the non-GAAP financial measures: adjusted gross profit margin, adjusted operating income and adjusted operating income margin, adjusted net earnings and adjusted net earnings per diluted share, to the most directly comparable GAAP measures: gross profit margin, operating income and operating income margin, net earnings and net earnings per diluted share, and other important information accompanies this press release. 1 (2) We are unable to present a quantitative reconciliation of our expected net sales growth to expected organic net sales growth as we are unable to predict with reasonable certainty and without unreasonable effort the impact and timing of acquisitions and divestitures and the impact of foreign currency exchange rates. We are unable to present a quantitative reconciliation of our expected net earnings per diluted share to
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.